These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 11520463

  • 1. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.
    Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH.
    Immunity; 2001 Aug; 15(2):289-302. PubMed ID: 11520463
    [Abstract] [Full Text] [Related]

  • 2. Activation and accumulation of B cells in TACI-deficient mice.
    Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T, Tumas D, Grewal IS, Dixit VM.
    Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
    [Abstract] [Full Text] [Related]

  • 3. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice.
    Wang H, Marsters SA, Baker T, Chan B, Lee WP, Fu L, Tumas D, Yan M, Dixit VM, Ashkenazi A, Grewal IS.
    Nat Immunol; 2001 Jul; 2(7):632-7. PubMed ID: 11429548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
    Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH.
    Nature; 2000 Apr 27; 404(6781):995-9. PubMed ID: 10801128
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.
    Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS.
    Immunity; 2003 Feb 27; 18(2):279-88. PubMed ID: 12594954
    [Abstract] [Full Text] [Related]

  • 8. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH.
    Arthritis Rheum; 2004 Jun 27; 50(6):1884-96. PubMed ID: 15188365
    [Abstract] [Full Text] [Related]

  • 9. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
    Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M, Grewal IS, Dixit VM.
    Curr Biol; 2001 Oct 02; 11(19):1547-52. PubMed ID: 11591325
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.
    Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A.
    Curr Biol; 2000 Jun 29; 10(13):785-8. PubMed ID: 10898980
    [Abstract] [Full Text] [Related]

  • 11. BLyS and APRIL in rheumatoid arthritis.
    Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM.
    J Clin Invest; 2005 Nov 29; 115(11):3083-92. PubMed ID: 16239971
    [Abstract] [Full Text] [Related]

  • 12. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, Sturm B, Poortman C, Minter RR, Dobson CL, Williams E, Carmen S, Smith R, Roschke V, Hilbert DM, Vaughan TJ, Albert VR.
    Arthritis Rheum; 2003 Nov 29; 48(11):3253-65. PubMed ID: 14613291
    [Abstract] [Full Text] [Related]

  • 13. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
    Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, McCabe S, Qiu WR, Kornuc M, Xia XZ, Guo J, Stolina M, Boyle WJ, Sarosi I, Hsu H, Senaldi G, Theill LE.
    Nat Immunol; 2000 Sep 29; 1(3):252-6. PubMed ID: 10973284
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.
    Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, Gan Y, Cho YH, Garcia AD, Gollatz E, Dimke D, LaFleur D, Migone TS, Nardelli B, Wei P, Ruben SM, Ullrich SJ, Olsen HS, Kanakaraj P, Moore PA, Baker KP.
    J Biol Chem; 2000 Nov 10; 275(45):35478-85. PubMed ID: 10956646
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the T-independent humoral response by TACI.
    von Bülow GU, van Deursen JM, Bram RJ.
    Immunity; 2001 May 10; 14(5):573-82. PubMed ID: 11371359
    [Abstract] [Full Text] [Related]

  • 16. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
    Xu S, Lam KP.
    Mol Cell Biol; 2001 Jun 10; 21(12):4067-74. PubMed ID: 11359913
    [Abstract] [Full Text] [Related]

  • 17. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
    Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J.
    J Exp Med; 2001 Dec 03; 194(11):1691-7. PubMed ID: 11733583
    [Abstract] [Full Text] [Related]

  • 18. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
    Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W, Gross JA, Greipp PR, Jelinek DF.
    Blood; 2004 Jan 15; 103(2):689-94. PubMed ID: 14512299
    [Abstract] [Full Text] [Related]

  • 19. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
    Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN.
    J Immunol; 2007 Jun 15; 178(12):7531-9. PubMed ID: 17548587
    [Abstract] [Full Text] [Related]

  • 20. B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.
    Dillon SR, Harder B, Lewis KB, Moore MD, Liu H, Bukowski TR, Hamacher NB, Lantry MM, Maurer M, Krejsa CM, Ellsworth JL, Pederson S, Elkon KB, Wener MH, Dall'Era M, Gross JA.
    Arthritis Res Ther; 2010 Jun 15; 12(2):R48. PubMed ID: 20302641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.